Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 53 citing articles:

Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Hideki Tani, Miyuki Kimura, Long Tan, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 68
Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
Qi Xiang, Linhao Li, Jie Wu, et al.
Microbiological Research (2022) Vol. 258, pp. 126993-126993
Open Access | Times Cited: 43
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives
Tao Dong, Mingyang Wang, Junchong Liu, et al.
Chemical Science (2023) Vol. 14, Iss. 23, pp. 6149-6206
Open Access | Times Cited: 35
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
Anwar M. Hashem, Abdullah Algaissi, Sarah A. Almahboub, et al.
Viruses (2020) Vol. 12, Iss. 12, pp. 1390-1390
Open Access | Times Cited: 55
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
Pauline Maisonnasse, Yoann Aldon, Aurélien Marc, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
Pia Gattinger, Anna Ohradanova‐Repic, Rudolf Valenta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5352-5352
Open Access | Times Cited: 19
Research progress in methods for detecting neutralizing antibodies against SARS-CoV-2
Chunxia Chen, Jiahui Liang, Hangzhan Hu, et al.
Analytical Biochemistry (2023) Vol. 673, pp. 115199-115199
Open Access | Times Cited: 16
Diketopiperazine/piperidine alkaloid as a potential broad-spectrum coronaviral entry inhibitor identified by supercomputer-based virtual screening from a large natural product-based library
Nasim Shahhamzehei, Sara Abdelfatah, Ejlal A. Omer, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117841-117841
Closed Access
Immune response against SARS-CoV-2 variants: the role of neutralization assays
Alicja Chmielewska, Anna Czarnota, Krystyna Bieńkowska-Szewczyk, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 34
Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses
Syamala Rani Thimmiraju, Jason T. Kimata, Jeroen Pollet
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 174-185
Open Access | Times Cited: 4
SARS-CoV-2 serology testing: Progress and challenges
Aria C. Shi, Ping Ren
Journal of Immunological Methods (2021) Vol. 494, pp. 113060-113060
Open Access | Times Cited: 27
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS‐CoV‐2 infection or vaccination
Deidre Wilkins, Anastasia A. Aksyuk, Alexey Ruzin, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 19
Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay
Ahmed M. Tolah, Sayed Sartaj Sohrab, Khaled Majdi K. Tolah, et al.
Diagnostics (2021) Vol. 11, Iss. 6, pp. 994-994
Open Access | Times Cited: 26
AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories
Y Victoria Zhang, Joesph R Wiencek, Qing H. Meng, et al.
Clinical Chemistry (2021) Vol. 67, Iss. 9, pp. 1188-1200
Open Access | Times Cited: 25
Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice
Sawsan S. Alamri, Khalid A. Alluhaybi, Rowa Y. Alhabbab, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 20
The importance of combining serological testing with RT-PCR assays for efficient detection of COVID-19 and higher diagnostic accuracy
Sawsan S. Alamri, Ahdab Alsaieedi, Yousef Khouqeer, et al.
PeerJ (2023) Vol. 11, pp. e15024-e15024
Open Access | Times Cited: 8
N‐glycosylation of the SARS‐CoV‐2 spike protein at Asn331 and Asn343 is involved in spike‐ACE2 binding, virus entry, and regulation of IL‐6
Tuhin Das, Shuhong Luo, Hao Tang, et al.
Microbiology and Immunology (2024) Vol. 68, Iss. 5, pp. 165-178
Open Access | Times Cited: 2
Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia
Rowa Y. Alhabbab, Ahdab Alsaieedi, Abdullah Algaissi, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1413-1413
Open Access | Times Cited: 19
Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods
Jo‐Lewis Banga Ndzouboukou, Yandi Zhang, Xionglin Fan
Current Medical Science (2021) Vol. 41, Iss. 6, pp. 1052-1064
Open Access | Times Cited: 19
Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus
Sharon Vijayanand, Smital Patil, Devyani Joshi, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1491-1491
Open Access | Times Cited: 12
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
Anwar M. Hashem, Abdullah Algaissi, Sarah A. Almahboub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 18
Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells
H. Caohuy, Ofer Eidelman, Tinghua Chen, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 17
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
Pauline Maisonnasse, Yoann Aldon, Aurélien Marc, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 13
Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
Khalid A. Alluhaybi, Rahaf Alharbi, Rowa Y. Alhabbab, et al.
Vaccines (2021) Vol. 9, Iss. 8, pp. 852-852
Open Access | Times Cited: 13
Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies
Osman Radhwi, Hamza Jan, Abdullah Waheeb, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 151-151
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top